http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#Head http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#assertion http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#provenance http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#pubinfo http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#assertion http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.informatics.jax.org/marker/MGI:88388 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.obolibrary.org/obo/CLO_0008172 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-diseases/Doxorubicin%20resistance http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/increases http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_1 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#assertion http://www.w3.org/2000/01/rdf-schema#label p(MGI:Cftr) -> path(SDIS:"Doxorubicin resistance") http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_4 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_3 http://www.w3.org/ns/prov#value we have analyzed chemotherapeutic drug resistance for NIH 3T3 cells overexpressing different levels of functional CFTR. Three separate clones not previously exposed to chemotherapeutic drugs exhibit resistance to doxorubicin, vincristine, and colchicine that is similar to MDR transfectants not previously exposed to chemotherapeutic drugs. http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/8519988 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/8519988 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#_3 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk#pubinfo http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk http://purl.org/dc/terms/created 2014-07-03T14:33:49.791+02:00 http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAvAfATCEuzqlxlImp2SGWiRVJrzd4k--o1aiBdEjg6Mk http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234